41. Activation of Liver X Receptors by GW3965 Attenuated Deoxycorticosterone Acetate–Salt Hypertension-Induced Cardiac Functional and Structural Changes. Issue 2 (August 2019) Authors: Bal, Nur Banu; Han, Sevtap; Usanmaz, Suzan Emel; Kiremitci, Saba; Sadi, Gökhan; Uludag, Orhan; Demirel-Yilmaz, Emine Journal: Journal of cardiovascular pharmacology Issue: Volume 74:Issue 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
42. Activation of Paraventricular Melatonin Receptor 2 Mediates Melatonin-Conferred Cardioprotection Against Myocardial Ischemia/Reperfusion Injury. Issue 2 (August 2020) Authors: Zhang, Chao; Yang, Jin-Bao; Quan, Wei; Feng, Ying-Da; Feng, Jian-Yu; Cheng, Liu-Siyuan; Li, Xiao-Qiang; Zhang, Hui-Nan; Chen, Wen-Sheng Journal: Journal of cardiovascular pharmacology Issue: Volume 76:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
43. Activation of Peroxisome Proliferator-activated Receptor γ Prevents Development of Heart Failure With Preserved Ejection Fraction; Inhibition of Wnt-β-catenin Signaling as a Possible Mechanism. Issue 2 (August 2016) Authors: Kamimura, Daisuke; Uchino, Kazuaki; Ishigami, Tomoaki; Hall, Michael E.; Umemura, Satoshi Journal: Journal of cardiovascular pharmacology Issue: Volume 68:Issue 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
44. Acute Effects of Interleukin-1 Blockade Using Anakinra in Patients With Acute Pericarditis. Issue 1 (July 2020) Authors: Wohlford, George F.; Buckley, Leo F.; Vecchié, Alessandra; Kadariya, Dinesh; Markley, Roshanak; Trankle, Cory R.; Chiabrando, Juan Guido; de Chazal, Horacio Medina; Van Tassell, Benjamin; Abbate, Antonio Journal: Journal of cardiovascular pharmacology Issue: Volume 76:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
45. Acylated Ghrelin Attenuates L-Thyroxin–induced Cardiac Damage in Rats by Antioxidant and Anti-inflammatory Effects and Downregulating Components of the Cardiac Renin–angiotensin System. Issue 3 (September 2021) Authors: Badi, Rehab Journal: Journal of cardiovascular pharmacology Issue: Volume 78:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
46. Add-on Therapy With Sacubitril/Valsartan and Clinical Outcomes in CRT-D Nonresponder Patients. Issue 4 (22nd April 2022) Authors: Russo, Vincenzo; Ammendola, Ernesto; Gasperetti, Alessio; Bottino, Roberta; Schiavone, Marco; Masarone, Daniele; Pacileo, Giuseppe; Nigro, Gerardo; Golino, Paolo; Lip, Gregory Y. H.; D'Andrea, Antonello; Boriani, Giuseppe; Proietti, Riccardo Journal: Journal of cardiovascular pharmacology Issue: Volume 79:Issue 4(2022) Page Start: 472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
47. Adrenal G Protein-Coupled Receptors and the Failing Heart: A Long-distance, Yet Intimate Affair. Issue 3 (September 2022) Authors: Borges, Jordana I.; Ferraino, Krysten E.; Cora, Natalie; Nagliya, Deepika; Suster, Malka S.; Carbone, Alexandra M.; Lymperopoulos, Anastasios Journal: Journal of cardiovascular pharmacology Issue: Volume 80:Issue 3(2022) Page Start: 386 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
48. Adrenergic Receptor Regulation of Mitochondrial Function in Cardiomyocytes: Erratum. Issue 5 (November 2022) Journal: Journal of cardiovascular pharmacology Issue: Volume 80:Issue 5(2022) Page Start: 753 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
49. Advances in Nanoformulated Polyphenols for Protection Against Cardiovascular Diseases. Issue 5 (November 2022) Authors: Sharma, Prasanti; Sharma, Neelima Journal: Journal of cardiovascular pharmacology Issue: Volume 80:Issue 5(2022) Page Start: 648 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
50. Advancing Beyond Failed High-density Lipoprotein Clinical Trials to Pharmacogenetic Studies of ADCY9 and Cholesterol Ester Transfer Protein Inhibition. Issue 4 (October 2021) Authors: Black, Donald M.; Miller, Michael; Heinonen, Therese M.; Zhang, Guili Journal: Journal of cardiovascular pharmacology Issue: Volume 78:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗